The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Cystic Fibrosis Foundation Evidence-Based Guidelines for Management of Infants with Cystic Fibrosis
Open accessAbstract
Newborn screening for cystic fibrosis (CF) offers the opportunity for early medical and nutritional intervention that can lead to improved outcomes. Management of the asymptomatic infant diagnosed with CF through newborn screening, prenatal diagnosis, or sibling screening is different from treatment of the symptomatically diagnosed individual. The focus of management is on maintaining health by preventing nutritional and respiratory complications. The CF Foundation convened a committee to develop recommendations based on a systematic review of the evidence and expert opinion. These guidelines encompass monitoring and treatment recommendations for infants diagnosed with CF and are intended to help guide families, primary care providers, and specialty care centers in the care of infants with CF. (J Pediatr 2009;155:S73–93).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
Computed Tomography — An Increasing Source of Radiation Exposure
Brenner, D. J., & Hall, E. J. (2007) · New England Journal of Medicine · doi:10.1056/nejmra072149 · Cited by 8,748
Update on Key Emerging Challenges in Cystic Fibrosis
Jennings, M. T., Riekert, K. A., & Boyle, M. P. (2014) · Medical Principles and Practice · doi:10.1159/000357646 · Cited by 3,648
Early pulmonary inflammation in infants with cystic fibrosis.
Khan, T. Z., Wagener, J. S., Bost, T., Martinez, J., Accurso, F. J., & Riches, D. W. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.4.7697234 · Cited by 1,263
Self-citationHealthcare Infection Control Practices Advisory Committee
Washington, R., & Fishman, N. O. (2012) · Cited by 1,038
Cystic Fibrosis Pulmonary Guidelines: Chronic Medications for Maintenance of Lung Health
Flume, P. A., O'Sullivan, B. P., Robinson, K. A., Goss, C. H., Mogayzel, P. J., Willey-Courand, D. B., Bujan, J., Finder, J., Lester, M., Quittell, L., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200705-664oc · Cited by 1,024
Self-citationEmerson, J., Rosenfeld, M., McNamara, S., Ramsey, B., & Gibson, R. L. (2002) · Pediatric Pulmonology · doi:10.1002/ppul.10127 · Cited by 1,007
Self-citationStallings, V. A., Stark, L. J., Robinson, K. A., Feranchak, A. P., & Quinton, H. (2008) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2008.02.020 · Cited by 732
Self-citationKleinman, R. E. (2003) · Cited by 652
Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice
Castellani, C., Cuppens, H., Macek, M., Cassiman, J. J., Kerem, E., Durie, P., Tullis, E., Assael, B. M., Bombieri, C., Brown, A., et al. (2008) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2008.03.009 · Cited by 601
Self-citation
Research works printed but not linked: 41
- Shepherd, 1989, Total body potassium in cystic fibrosis, J Pediatr Gastroenterol Nutr, 9, 200, 10.1097/00005176-198908000-00012 · doi:10.1097/00005176-198908000-00012
- Borowitz, 2005, Update on the evaluation of pancreatic exocrine status in cystic fibrosis, Curr Opin Pulm Med, 11, 524, 10.1097/01.mcp.0000181474.08058.b3 · doi:10.1097/01.mcp.0000181474.08058.b3
- Walkowiak, 2005, Early decline of pancreatic function in cystic fibrosis patients with class 1 or 2 CFTR mutations, J Pediatr Gastroenterol Nutr, 40, 199, 10.1097/00005176-200502000-00022 · doi:10.1097/00005176-200502000-00022
- Bellentani, 1984, BT-Paba test in the diagnosis of pancreatic exocrine insufficiency in cystic fibrosis: urinary and serum determinations compared, Eur J Pediatr, 143, 145, 10.1007/BF00445804 · doi:10.1007/bf00445804
- Greer, 1991, Evaluation of growth and changes in body composition following neonatal diagnosis of cystic fibrosis, J Pediatr Gastroenterol Nutr, 13, 52, 10.1097/00005176-199107000-00010 · doi:10.1097/00005176-199107000-00010
- Durie, 1981, Plasma immunoreactive pancreatic cationic trypsinogen in cystic fibrosis: a sensitive indicator of exocrine pancreatic dysfunction, Pediatr Res, 15, 1351, 10.1203/00006450-198110000-00010 · doi:10.1203/00006450-198110000-00010
- Colombo, 1987, The steatocrit: a simple method for monitoring fat malabsorption in patients with cystic fibrosis, J Pediatr Gastroenterol Nutr, 6, 926, 10.1097/00005176-198711000-00018 · doi:10.1097/00005176-198711000-00018
- Remtulla, 1986, Stool chymotrypsin activity measured by a spectrophotometric procedure to identify pancreatic disease in infants, Clin Biochem, 19, 341, 10.1016/S0009-9120(86)80007-8 · doi:10.1016/s0009-9120(86)80007-8
- Nissler, 2001, Pancreatic elastase 1 in feces of preterm and term infants, J Pediatr Gastroenterol Nutr, 33, 28, 10.1097/00005176-200107000-00005 · doi:10.1097/00005176-200107000-00005
- McClean, 1993, Measurement of fat digestion in early life using a stable isotope breath test, Arch Dis Child, 69, 366, 10.1136/adc.69.3.366 · doi:10.1136/adc.69.3.366
- Borowitz, 1995, Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy: consensus committee, J Pediatr, 127, 681, 10.1016/S0022-3476(95)70153-2 · doi:10.1016/s0022-3476(95)70153-2
- Schwarzenberg, 1995, Cystic fibrosis-associated colitis and fibrosing colonopathy, J Pediatr, 127, 565, 10.1016/S0022-3476(95)70113-3 · doi:10.1016/s0022-3476(95)70113-3
- Holliday, 1991, Growth of human milk-fed and formula-fed infants with cystic fibrosis, J Pediatr, 118, 77, 10.1016/S0022-3476(05)81850-5 · doi:10.1016/s0022-3476(05)81850-5
- Ellis, 1998, Do infants with cystic fibrosis need a protein hydrolysate formula? A prospective, randomized comparitive trial, J Pediatr, 132, 270, 10.1016/S0022-3476(98)70444-5 · doi:10.1016/s0022-3476(98)70444-5
- Canciani, 1985, Absorption of a new semielemental diet in infants with cystic fibrosis, J Pediatr Gastroenterol Nutr, 4, 735, 10.1097/00005176-198510000-00009 · doi:10.1097/00005176-198510000-00009
- Rayner, 1989, Night blindness and conjunctival xerosis caused by vitamin A deficiency in patients with cystic fibrosis, Arch Dis Child, 64, 1151, 10.1136/adc.64.8.1151 · doi:10.1136/adc.64.8.1151
- Sitrin, 1987, Vitamin E deficiency and neurologic disease in adults with cystic fibrosis, Ann Intern Med, 107, 51, 10.7326/0003-4819-107-1-51 · doi:10.7326/0003-4819-107-1-51
- Easley, 1998, Effect of pancreatic enzymes on zinc absorption in cystic fibrosis, J Pediatr Gastroenterol Nutr, 26, 136, 10.1097/00005176-199802000-00003 · doi:10.1097/00005176-199802000-00003
- Arvanitakis, 1973, Metabolic alkalosis and salt depletion in cystic fibrosis, J Pediatr, 82, 535, 10.1016/S0022-3476(73)80139-8 · doi:10.1016/s0022-3476(73)80139-8
- Laughlin, 1981, Changing feeding trends as a cause of electrolyte depletion in infants with cystic fibrosis, Pediatrics, 68, 203, 10.1542/peds.68.2.203 · doi:10.1542/peds.68.2.203
- Ozcelik, 1994, Sodium chloride deficiency in cystic fibrosis patients, Eur J Pediatr, 153, 829, 10.1007/BF01972892 · doi:10.1007/bf01972892
- Coates, 2005, Prospective audit of salt supplementation in CF infants, Pediatr Pulmonol Suppl, 28, 345
- Steinkamp, 2000, Energy supplements rich in linoleic acid improve body weight and essential fatty acid status of cystic fibrosis patients, J Pediatr Gastroenterol Nutr, 31, 418, 10.1097/00005176-200010000-00016 · doi:10.1097/00005176-200010000-00016
- Gilljam, 1990, Passive smoking in cystic fibrosis, Respir Med, 84, 289, 10.1016/S0954-6111(08)80055-8 · doi:10.1016/s0954-6111(08)80055-8
- Maayan, 1989, Immediate effect of various treatments on lung function in infants with cystic fibrosis, Respiration, 55, 144, 10.1159/000195725 · doi:10.1159/000195725
- Button, 2004, Chest physiotherapy, gastro-oesophageal reflux, and arousal in infants with cystic fibrosis, Arch Dis Child, 89, 435, 10.1136/adc.2003.033100 · doi:10.1136/adc.2003.033100
- Kosorok, 1998, Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis, Pediatr Pulmonol, 26, 81, 10.1002/(SICI)1099-0496(199808)26:2<81::AID-PPUL2>3.0.CO;2-K · doi:10.1002/(sici)1099-0496(199808)26:2<81::aid-ppul2>3.0.co;2-k
- 2009, Recommended childhood and adolescent immunization schedules–United States, 2009, Pediatrics, 123, 189, 10.1542/peds.2008-3306 · doi:10.1542/peds.2008-3306
- Speer, 2008, Use of Palivizumab for prevention of hospitalization as a result of respiratory syncytial virus in infants with cystic fibrosis, Pediatr Infect Dis J, 27, 559, 10.1097/INF.0b013e3181673c15 · doi:10.1097/inf.0b013e3181673c15
- Rosenfeld, 1999, Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis, Pediatr Pulmonol, 28, 321, 10.1002/(SICI)1099-0496(199911)28:5<321::AID-PPUL3>3.0.CO;2-V · doi:10.1002/(sici)1099-0496(199911)28:5<321::aid-ppul3>3.0.co;2-v
- Harrison, 1985, A multicenter comparison of related pharmacologic features of cephalexin and dicloxacillin given for two months to young children with cystic fibrosis, Pediatr Pharmacol, 5, 7
- Wright, 1970, Fusidic acid and lincomycin therapy in staphylococcal infections in cystic fibrosis, Lancet, 1, 9, 10.1016/S0140-6736(70)90523-4 · doi:10.1016/s0140-6736(70)90523-4
- Ratjen, 2008, Short and long-term efficacy of inhaled tobramycin in early P. aeruginosa infection: the ELITE study, Pediatr Pulm, 319
- Tepper, 1988, Infants with cystic fibrosis: pulmonary function at diagnosis, Pediatr Pulmonol, 5, 15, 10.1002/ppul.1950050105 · doi:10.1002/ppul.1950050105
- Villa, 2001, Nocturnal oximetry in infants with cystic fibrosis, Arch Dis Child, 84, 50, 10.1136/adc.84.1.50 · doi:10.1136/adc.84.1.50
- Martinez, 2005, High-resolution computed tomography imaging of airway disease in infants with cystic fibrosis, Am J Respir Crit Care Med, 172, 1133, 10.1164/rccm.200412-1665OC · doi:10.1164/rccm.200412-1665oc
- Lynch, 1990, Pediatric pulmonary disease: assessment with high-resolution ultrafast CT, Radiology, 176, 243, 10.1148/radiology.176.1.2353097 · doi:10.1148/radiology.176.1.2353097
- Turner, 1994, Improved detection of abnormal respiratory function using forced expiration from raised lung volume in infants with cystic fibrosis, Eur Respir J, 7, 1995, 10.1183/09031936.94.07111995 · doi:10.1183/09031936.94.07111995
- Kraemer, 1989, Early detection of lung function abnormalities in infants with cystic fibrosis, J R Soc Med, 82, 21
- Beardsmore, 1988, Lung function in infants with cystic fibrosis, Thorax, 43, 545, 10.1136/thx.43.7.545 · doi:10.1136/thx.43.7.545
- Godfrey, 1978, Serial lung function studies in cystic fibrosis in the first 5 years of life, Arch Dis Child, 53, 83, 10.1136/adc.53.1.83 · doi:10.1136/adc.53.1.83
Cited by
The future of cystic fibrosis care: a global perspective
Bell, S. C., Mall, M. A., Gutierrez, H., Macek, M., Madge, S., Davies, J. C., Burgel, P.-R., Tullis, E., Castaños, C., Castellani, C., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30337-6 · Cited by 974
Self-citationDiagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation
Farrell, P. M., White, T. B., Ren, C. L., Hempstead, S. E., Accurso, F., Derichs, N., Howenstine, M., McColley, S. A., Rock, M., Rosenfeld, M., et al. (2017) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2016.09.064 · Cited by 953
Self-citationECFS best practice guidelines: the 2018 revision
Castellani, C., Duff, A. J. A., Bell, S. C., Heijerman, H. G. M., Munck, A., Ratjen, F., Sermet-Gaudelus, I., Southern, K. W., Barben, J., Flume, P. A., et al. (2018) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2018.02.006 · Cited by 765
The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update
Reynolds, D., & Kollef, M. (2021) · Drugs · doi:10.1007/s40265-021-01635-6 · Cited by 721
European cystic fibrosis society standards of care: best practice guidelines
Smyth, A. R., Bell, S. C., Bojcin, S., Bryon, M., Duff, A., Flume, P., Kashirskaya, N., Munck, A., Ratjen, F., Schwarzenberg, S. J., et al. (2014) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2014.03.010 · Cited by 582
Metadata
- Authors
- Borowitz, D., Robinson, K. A., Rosenfeld, M., Davis, S. D., Sabadosa, K. A., Spear, S. L., Michel, S. H., Parad, R. B., White, T. B., Farrell, P. M., Marshall, B. C., & Accurso, F. J.
- Venue
- The Journal of Pediatrics
- Publisher
- Elsevier BV
- Published
- 2009-12
- Volume
- 155
- Issue
- 6
- Pages
- S73-S93
- ISSN
- 0022-3476 (ISSN-L)
- OpenAlex
- W2104682204
- Cited by
- 456
- References
- 109
- FWCI
- 15.50
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cystic Fibrosis Foundation Evidence-Based Guidelines for Management of Infants with Cystic Fibrosis. https://app.cochat.ai/papers/10.1016/j.jpeds.2009.09.001
- The paper
- Borowitz, D., Robinson, K. A., Rosenfeld, M., Davis, S. D., Sabadosa, K. A., Spear, S. L., Michel, S. H., Parad, R. B., White, T. B., Farrell, P. M., Marshall, B. C., & Accurso, F. J. (2009). Cystic Fibrosis Foundation Evidence-Based Guidelines for Management of Infants with Cystic Fibrosis. The Journal of Pediatrics. https://doi.org/10.1016/j.jpeds.2009.09.001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.